MedPath

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Completed
Conditions
Lung Cancer
Registration Number
NCT00185913
Lead Sponsor
Stanford University
Brief Summary

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors
Exclusion Criteria
  • Patients without non-small cell lung cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University School of Medicine

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

Stanford University School of Medicine
πŸ‡ΊπŸ‡ΈStanford, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.